Ikarian Capital, LLC Cytokinetics Inc Call Options Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $2.68 Million - $3.15 Million	52,300 New	52,300 $2.76 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $16.2 Million - $50.2 Million	601,465 Added 29556.02%	603,500 $50.4 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $59,951 - $74,501	2,035 New	2,035 $59,000
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $15.6 Million - $29.2 Million	-1,021,600 Reduced 87.2%	150,000 $3.12 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $24.1 Million - $33.9 Million	1,171,600 New	1,171,600 $25.4 Million
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $5.58 Million - $12.3 Million	-500,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $4.38 Million - $8.15 Million	500,000 New	500,000 $5.9 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.